NUKEMS (or NI-UKEMS) was established in 2017 and aims to actively represent New Investigators (NIs) within UKEMS and its linked societies. NIs are scientists with the equivalent of up to 4-6 years of post-doctoral experience, working/ studying in academia or industry.
The NUKEMS committee is made up of NIs from both industry and academia, and consists of the Chair, Vice-Chair, Secretary, Membership Secretary, and currently, 6 ordinary members.
NUKEMS runs the ‘Sunday Session’ at UKEMS, traditionally held as an educational session prior to the main annual conference. Past sessions have included:
- Poster pitches/ talks with peer voting and prizes
- Senior UKEMS scientist panel discussions on what makes a good interview candidate
- Mock job interviews with audience participation
- Personal career progression talks by senior UKEMS scientists
- Socialising with other NIs
2020 has presented us with a unique set of circumstances, so we will be delivering some of our usual session content online – keep an eye on our social media and these pages! Our committee is here to support UKEMS NIs, so please get in touch with any ideas on what you would like to see from us.
Remember to become a UKEMS member and follow our social media for updates!
Follow us on Twitter: NIUKEMS
Connect with us on LinkedIn: NI UKEMS
Follow us on Instagram: niukems
Meet our New Investigator committee
Dr Fiona Chapman
I joined the NUKEMS committee as Secretary in 2017, during my studies for my PhD on exposure science in in vitro genetic toxicology at Swansea University (supervised by current UKEMS President, Prof. Gareth Jenkins). Following my PhD, I worked on in vitro toxicology in drug development at Cardiff University before starting my current position as a Pre-Clinical Toxicologist at Imperial Brands. I became Chair of the NUKEMS committee in April 2020. I have been a member of UKEMS since 2015 and am very grateful for the amazing support they offer to their New Investigators, from opportunities to present to a great selection of funding opportunities.
Dr Beth Rogoyski
Dr Beth Rogoyski completed her PhD under UKEMS former president Prof. Karen Brown at the University of Leicester in mesothelioma prevention and drug repurposing. Although still an honorary fellow in Karen’s research group, Beth now deputy leads the Biomedical Sciences Programme at De Montfort University, and lectures on a few undergraduate and postgraduate courses. Beth is generally a keen educator and communicator, having co-created lecturemotely.com providing resources and advice for online teaching, and runs phdoodles.com. In any remaining spare time, Beth is an LGBTQ+ and Women in STEM equality advocate, amateur artist, and lazy sportswoman.
Mr Alan Dawson
Dr Lucy Swithenbank
Hi I am Lucy Swithenbank and I hold the position of membership secretary on the NIUKEMS committee. Outside of this role I work at Swansea University within the Genomic Medicine program. I previously completed my PhD at Swansea University as part of the Genetic Toxicology research group. I have been part of UKEMS for the last 5 years and I really look forward to supporting all of the New Investigators through their early career progression in such a great society.
Ordinary Member/ Social Media
I’m Demi, I’m currently in the third year of my PhD entitled ‘Developing an in vitro repeat-dose approach to detect non-genotoxic carcinogens (NGCs)’ at Swansea University.
Ordinary Member/ Social Media
I am a second year PhD student with the In Vitro Toxicology Group at Swansea University. My project is in collaboration with AstraZeneca and investigates the use of automated high content imaging for carcinogenicity testing in vitro. I obtained my Bachelor of Science and Masters in Toxicology from the National University of Ireland, Galway. Prior to starting my PhD, I was a Trainee in the Scientific Committee and Emerging Risks unit at the European Food Safety Authority and worked as a Junior Toxicologist at Delphic HSE.
Hi, I am Anup. Ever since early age, I was curious about science and innovation, mainly working in laboratory and creating something novel. This curiosity transformed into passion motivating me through my education at University of Huddersfield where I completed my undergraduate in Bachelor of Science (Hons) Microbial Sciences followed by Masters of Science in Infection, Immunity and Human Disease from University of Leeds. This is where I developed my scientific skills and resources that aspired to carry out my passion as a career.
I joined Covance in 2017 as a Research assistant in Genetic Toxicology Department. My job role involves carrying out in vitro assays such as in vitro micronucleus and chromosomal aberration assays to identify the substances that causes genotoxicity/DNA damage and structural chromosomal aberrations ensuring the safety of the compounds in the process of early drug development. Apart from this, I also carry out non-standard projects such as validation and trial projects, check laboratory stocks and supplies, training new staffs and liaising with professionals to carry out daily lab process smoothly. I enjoy my work as it had fulfilled my passion to work in lab and fuels to learn new things every day.
Besides science and work, I am a yoga enthusiast. I practice yoga and mindfulness which helps me to manage my work challenges, remain balance and stay productive. I also enjoy travelling as this connects me to the variety of people, their cultures and backgrounds.
Dr Rebekah Beck
During my PhD at the University of Manchester, I developed a keen interest in the effect that pharmaceutical and environmental compounds have on the DNA methylome signature. In 2019, I started my first postdoc in the David Phillips group at King’s College London. Continuing along a similar vein of research, I focus on establishing mutational signatures of defined mutagens as part of the Mutographs of Cancer – CRUK Grand Challenge Project.
Harshini Shanika Asurappulige, BSc. in Biomedical Science (University of Northumbria, Newcastle), MSc. in Cellular and Molecular Immunology (University of Colombo, Sri Lanka). PhD in Cancer Research (University of the West of England, Bristol): working on, Identifying the genetic polymorphism of cytokines followed by chemotherapies and recognise cytotoxicity/genotoxicity against BM/HSC in haematopoietic stem cell transplantation.